✦ LIBER ✦

A phase II evaluation of tamoxifen in unresectable or refractory meningiomas: a southwest oncology group study

✍ Scribed by J. Wendall Goodwin; John Crowley; Harmon J. Eyre; Benjamin Stafford; Kurt A. Jaeckle; Jeannette J. Townsend

Publisher: Springer US
Year: 1993
Tongue: English
Weight: 252 KB
Volume: 15
Category: Article
ISSN: 0167-594X
DOI: 10.1007/bf01050266

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II evaluation of cisplatin in un

A phase II evaluation of cisplatin in unresectable diffuse malignant mesothelioma: A Southwest Oncology Group Study

✍ Bernard L. Zidar; Stephanie Green; H. I. Pierce; Ralph W. Roach; Stanley P. Balc 📂 Article 📅 1988 🏛 Springer US 🌐 English ⚖ 240 KB

Cisplatin was given intravenously to 35 evaluable patients with unresectable malignant mesothelioma on Southwest Oncology Group (SWOG) Study 8418. Five patients (14.3%) achieved partial response with median response duration of six months (range 2-12 months); eleven patients (31.4%) had stable disea

Phase II evaluation of bleomycin. A Sout

Phase II evaluation of bleomycin. A Southwest Oncology Group study

✍ Charles D. Haas; Charles A. Coltman Jr.; Jeffrey A. Gottlieb; Arthur Haut; James 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 369 KB 👁 2 views

Bleomycin given intravenously (i.v.) or intramuscularly (i.m.) in twice-weekly doses of 10 mg/mz was evaluated for efficacy and toxicity in 382 patients. Responses were observed in 11/27 Hodgkin's diseases, 10/30 lymphomas, 9/22 squamous cell cancers of ectodermal origin, 12/26 germinal cancers, and

A phase II evaluation of ifosfamide and

A phase II evaluation of ifosfamide and mesna in unresectable diffuse malignant mesothelioma: A southwest oncology group study

✍ Bernard L. Zidar; Barbara Metch; Stanley P. Balcerzak; H. Irving Pierce; Liboria 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 531 KB

Phase II evaluation of mitoxantrone in a

Phase II evaluation of mitoxantrone in advanced pancreatic carcinoma: A Southwest Oncology Group study

✍ Sarah A. Taylor; Thomas Fleming; Daniel D. Hoff; Joseph D. McCracken; Ronald M. 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 242 KB

Patient with advanced adenocarcinoma of the pancreas and no prior chemotherapy were treated on a Phase II trial of mitoxantrone. Doses were adjusted for hepatic dysfunction as defined by bilirubin. Twenty-four patients with a bilirubin less than or equal to 1.5 mg% received mitoxantrone 12 mg/m2 i.v

A Southwest Oncology Group phase II eval

A Southwest Oncology Group phase II evaluation of fluderabine monophosphate in sarcoma

✍ Micheal R. Grever; Jacqueline Benedetti; Stanley P. Balcerzak; Sarah A. Taylor; 📂 Article 📅 1994 🏛 Springer US 🌐 English ⚖ 188 KB

Phase ii evaluation of ftorafur in previ

Phase ii evaluation of ftorafur in previously untreated colorectal cancer: A southwest oncology group study

✍ Thomas Buroker; Fernando Padilla; Carl Groppe; Gerald Guy; Joseph Quagliana; Jos 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 341 KB 👁 2 views